# Daniel Krizek

> Daniel Krizek is a Series B investor at Brookside Capital backing Genetics and Health Care. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Brookside Capital](https://shizune.co/investors/profile/brookside-capital)
- Location: Boston, United States
- Total investments: 1
- Last investment: Apr 2015
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/danielkrizek

Daniel Krizek is a Series B investor at Brookside Capital in Boston focused on Genetics and Health Care. Daniel Krizek - Director @ Brookside Capital

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Genetics | 1 | 100% |
| Health Care | 1 | 100% |
| Life Science | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Voyager Therapeutics | Voyager Therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS). Voyager is committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector optimization and engineering, dosing techniques, as well asprocess development and production.The company’s initial pipeline is focused on CNS diseases in dire need of effective new therapies, including Parkinson’s disease, a monogenic form of amyotrophic lateral sclerosis (ALS), and Friedreich’s ataxia.Founded by scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference and neuroscience, Voyager Therapeutics was launched in 2014 with funding from leading life sciences investor Third Rock Ventures and is headquartered in Cambridge, Mass. |  | Series B | Apr 13, 2015 |  |

1 of 1 investments shown.

## About Brookside Capital

VC Fund · San Francisco, United States

They design, implement, and manage custom tailored portfolios of liquid assets for high net worth investors.

5 contacts available at Brookside Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Daniel Krizek | Director | https://shizune.co/investors/profile/daniel-krizek |
| Thomas L. Rea | Board of Advisors | https://shizune.co/investors/profile/thomas-l-rea |
| Craig Law | Operations Manager | https://shizune.co/investors/profile/craig-law |
| Doreen Marino | Director of Client Services | https://shizune.co/investors/profile/doreen-marino |
| James Rea | President | https://shizune.co/investors/profile/james-rea |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Daniel Krizek invest in?

Daniel Krizek invests primarily in Genetics, Health Care and Life Science startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Daniel Krizek last invest?

The most recent investment recorded for Daniel Krizek closed in Apr 2015. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co